Grant ID RP180394
Awarded On February 21, 2018
Title Targeting the metastatic sarcoma niche using leukocyte biomimetic nanoparticles
Program Academic Research
Award Mechanism Individual Investigator Research Awards for Cancer in Children and Adolescents
Institution/Organization The Methodist Hospital Research Institute
Principal Investigator/Program Director Ennio Tasciotti
Cancer Sites Bone, Sarcoma
Contracted Amount $1,199,617
Lay Summary

Osteosarcoma (OS) is the most common bone tumor in the pediatric population. Patients that present or develop disseminated or metastatic disease have extremely poor survival rates. OS metastasizes via the blood stream and most frequently develops lesions in the lungs. The poor survival rates associated with a metastatic disease are a clear indication that present therapies are ineffective. Our proposed technology aims to revolutionize the current treatment of metastatic OS by developing therapies that are more effective, less toxic, and target the key pathways that govern the growth and progression of the metastatic OS cells. We will accomplish this by capturing therapeutics within a nanopar...

Read More